Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.30 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25468119 | 1.00 | GBA1 (0.33) | GBA1CYP3A4CYP1A2CYP2D6HRH3 | |
| SCHEMBL23518605 | 1.00 | GBA1 (0.33) | GBA1CYP3A4CYP1A2CYP2D6HRH3 | |
| SCHEMBL23945284 | 0.92 | HRH3 (0.36) | GBA1HRH3CARM1PRMT6NPC1 | |
| SCHEMBL18270428 | 0.90 | HRH3 (0.33) | CYP3A4CYP1A2CYP2D6HRH3CARM1 | |
| SCHEMBL26227368 | 0.87 | GBA1 (0.34) | GBA1HRH3CARM1PRMT6NPC1 | |
| SCHEMBL24508707 | 0.87 | HRH3 (0.38) | GBA1HRH3CARM1PRMT6NPC1 | |
| SCHEMBL21107437 | 0.87 | HRH3 (0.38) | GBA1HRH3CARM1PRMT6NPC1 | |
| SCHEMBL22861793 | 0.87 | HRH3 (0.38) | GBA1HRH3CARM1PRMT6NPC1 | |
| SCHEMBL25654268 | 0.86 | GBA1 (0.30) | GBA1 | |
| SCHEMBL17033973 | 0.84 | LIPC (0.38) | CYP2D6HRH3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021119159-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021011868-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2021-01-21 | — | — | WO | disclosed |